Factors associated with gastrointestinal side effects after liraglutide treatment for type 2 diabetes

AIM: To identify risk factors predictive of or associated with gastrointestinal side effects (GISE) of liraglutide in patients with type 2 diabetes (T2DM). METHODS: T2DM patients treated with liraglutide for the first time were obtained and grouped into patients without GSEA and patients with GSEA....

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Hao, Lu, Zongshi, Chen, Runyao, Cai, Quanfang, Wang, Miaomiao, Zhang, Liting, Zhu, Zhiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922750/
https://www.ncbi.nlm.nih.gov/pubmed/36793278
http://dx.doi.org/10.3389/fendo.2023.1098032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922750/
https://www.ncbi.nlm.nih.gov/pubmed/36793278
http://dx.doi.org/10.3389/fendo.2023.1098032

Ejemplares similares